Botulinum toxin type A injection after failure of augmentation enterocystoplasty performed for neurogenic detrusor overactivity: preliminary results of a salvage strategy. The ENTEROTOX study

To evaluate the clinical efficacy, urodynamic effect and safety of Botulinum Toxin A (BTXA) injections after failure of augmentation enterocystoplasty (AE) performed for NDO.

Source: Urology - March 25, 2019 Category: Urology & Nephrology Authors: Floriane Michel, Carine Ciceron, Benjamin Bernuz, Romain Boissier, Sarah Gaillet, Alexia Even, Emmanuel Chartier-Kastler, Pierre Denys, Xavier Gam é, Alain Ruffion, Loïc Le Normand, Brigitte Perrouin-Verbe, Christian Saussine, Andrea Manunta, Véronique Source Type: research